Ring KL - Search Results

1

Potential immunotherapy targets in recurrent cervical cancer.

Ring KL, Yemelyanova AV, Soliman PT, Frumovitz MM, Jazaeri AA. Ring KL, et al. Gynecol Oncol. 2017 Jun;145(3):462-468. doi: 10.1016/j.ygyno.2017.02.027. Epub 2017 Feb 21. Gynecol Oncol. 2017. PMID: 28233576

2

Consequences of universal MSI/IHC in screening ENDOMETRIAL cancer patients for Lynch syndrome.

Batte BA, Bruegl AS, Daniels MS, Ring KL, Dempsey KM, Djordjevic B, Luthra R, Fellman BM, Lu KH, Broaddus RR. Batte BA, et al. Among authors: ring kl. Gynecol Oncol. 2014 Aug;134(2):319-25. doi: 10.1016/j.ygyno.2014.06.009. Epub 2014 Jun 14. Gynecol Oncol. 2014. PMID: 24933100 Free PMC article.

3

Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma.

Slomovitz BM, Jiang Y, Yates MS, Soliman PT, Johnston T, Nowakowski M, Levenback C, Zhang Q, Ring K, Munsell MF, Gershenson DM, Lu KH, Coleman RL. Slomovitz BM, et al. J Clin Oncol. 2015 Mar 10;33(8):930-6. doi: 10.1200/JCO.2014.58.3401. Epub 2015 Jan 26. J Clin Oncol. 2015. PMID: 25624430 Free PMC article. Clinical Trial.

4

One size may not fit all: the debate of universal tumor testing for Lynch syndrome.

Lu KH, Ring KL. Lu KH, et al. Among authors: ring kl. Gynecol Oncol. 2015 Apr;137(1):2-3. doi: 10.1016/j.ygyno.2015.03.011. Gynecol Oncol. 2015. PMID: 25818039 No abstract available.

5

Role of Minimally Invasive Surgery in Gynecologic Oncology: An Updated Survey of Members of the Society of Gynecologic Oncology.

Conrad LB, Ramirez PT, Burke W, Naumann RW, Ring KL, Munsell MF, Frumovitz M. Conrad LB, et al. Among authors: ring kl. Int J Gynecol Cancer. 2015 Jul;25(6):1121-7. doi: 10.1097/IGC.0000000000000450. Int J Gynecol Cancer. 2015. PMID: 25860841 Free PMC article.

6

Make New Friends But Keep the Old: Minimally Invasive Surgery Training in Gynecologic Oncology Fellowship Programs.

Ring KL, Ramirez PT, Conrad LB, Burke W, Wendel Naumann R, Munsell MF, Frumovitz M. Ring KL, et al. Int J Gynecol Cancer. 2015 Jul;25(6):1115-20. doi: 10.1097/IGC.0000000000000466. Int J Gynecol Cancer. 2015. PMID: 26067857 Free PMC article.

7

Immune Checkpoint Inhibitors in the Treatment of Gynecologic Malignancies.

Ring KL, Pakish J, Jazaeri AA. Ring KL, et al. Cancer J. 2016 Mar-Apr;22(2):101-7. doi: 10.1097/PPO.0000000000000179. Cancer J. 2016. PMID: 27111905 Review.

8

Tumor-associated macrophage expression of PD-L1 in implants of high grade serous ovarian carcinoma: A comparison of matched primary and metastatic tumors.

Gottlieb CE, Mills AM, Cross JV, Ring KL. Gottlieb CE, et al. Among authors: ring kl. Gynecol Oncol. 2017 Mar;144(3):607-612. doi: 10.1016/j.ygyno.2016.12.021. Epub 2017 Jan 5. Gynecol Oncol. 2017. PMID: 28065619

9

PD-L1 pitfalls: Emphasizing the importance of membranous localization and correlation with tumor cell and macrophage distributions.

Mills AM, Gottlieb C, Ring KL. Mills AM, et al. Among authors: ring kl. Gynecol Oncol Rep. 2017 Mar 23;20:135-136. doi: 10.1016/j.gore.2017.03.013. eCollection 2017 May. Gynecol Oncol Rep. 2017. PMID: 29892677 Free PMC article. No abstract available.

10

Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy.

Roszik J, Ring KL, Wani KM, Lazar AJ, Yemelyanova AV, Soliman PT, Frumovitz M, Jazaeri AA. Roszik J, et al. Among authors: ring kl. Front Immunol. 2018 Sep 19;9:2102. doi: 10.3389/fimmu.2018.02102. eCollection 2018. Front Immunol. 2018. PMID: 30283446 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters